Ann Vanderplas

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zheng Zhou, Laurie H. Sehn, Alfred Rademaker et al. · Blood · 2013 · 953 citations

Medicine, Hematology, Oncology +14

Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network

Nancy U. Lin, Ann Vanderplas, Melissa E. Hughes et al. · Cancer · 2012 · 706 citations · Full text

Medicine, Oncology, Breast Oncology +12

Adherence to oral antidiabetic therapy in a managed care organization: A comparison of monotherapy, combination therapy, and fixed-dose combination therapy

Caron Melikian, TJ White, Ann Vanderplas et al. · Clinical Therapeutics · 2002 · 238 citations

Pharmacy, Clinical Pharmacy, Pharmacotherapy +16

Costs of Lower-Extremity Ulcers Among Patients With Diabetes

Karen M. Stockl, Ann Vanderplas, Eskinder Tafesse et al. · Diabetes Care · 2004 · 197 citations · Full text

Medicine, Geriatric Medicine, Surgery +12

Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database

Ann S. LaCasce, Jonathan L. Vandergrift, Maria Alma Rodriguez et al. · Blood · 2012 · 98 citations · Full text

Medicine, Hematology, Oncology +10